HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification of dopamine receptor subtypes in the hypotensive action of SK&F 85174 in anesthetized rats.

Abstract
1 We have performed experiments to determine the effect of SK&F 85174 on blood pressure in anaesthetized rats and identify dopamine receptor subtype(s) involved in its action. 2 SK&F 85174 decreased blood pressure in a dose-related manner. There were no significant changes in heart rate. The hypotensive action was short-lasting and was significantly antagonized by the selective DA1-receptor antagonist. SCH 23390 (100 micrograms/kg). This dose of SCH 23390 did not alter the hypotension produced by the DA2-receptor agonist, quinpirole. 3 The DA2-receptor antagonist, domperidone (25 micrograms/kg), did not significantly alter the hypotension produced by lower doses of SK&F 85174, but antagonized the hypotensive action of the highest dose of SK&F 85174 by about 35%. This dose of domperidone antagonized the hypotension produced by quinpirole by 85% without affecting the hypotensive action of the DA1-receptor agonist, fenoldopam. 4 These results show that at lower doses of SK&F 85174, the hypotension is due primarily to DA1-receptor activation, whereas DA2-receptor activation may also contribute to the blood pressure decrease produced by higher doses of SK&F 85174.
AuthorsB A Sowinski, M F Lokhandwala
JournalJournal of autonomic pharmacology (J Auton Pharmacol) Vol. 7 Issue 2 Pg. 105-9 (Jun 1987) ISSN: 0144-1795 [Print] England
PMID2888767 (Publication Type: Journal Article)
Chemical References
  • Antipsychotic Agents
  • Benzazepines
  • Ergolines
  • Receptors, Dopamine
  • Quinpirole
  • Domperidone
  • SK&F 85174
Topics
  • Anesthesia
  • Animals
  • Antipsychotic Agents (pharmacology)
  • Benzazepines (pharmacology)
  • Blood Pressure (drug effects)
  • Domperidone (pharmacology)
  • Ergolines (pharmacology)
  • Heart Rate (drug effects)
  • Male
  • Quinpirole
  • Rats
  • Rats, Inbred Strains
  • Receptors, Dopamine (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: